M H Ruttledge, J Sarrazin, S Rangaratnam, C M Phelan, E Twist, P Merel, O Delattre, G Thomas, M Nordenskjöld, V P Collins. Nat Genet 1994
Times Cited: 443
Times Cited: 443
Times Cited
Times Co-cited
Similarity
Genomic analysis of non-NF2 meningiomas reveals mutations in TRAF7, KLF4, AKT1, and SMO.
Victoria E Clark, E Zeynep Erson-Omay, Akdes Serin, Jun Yin, Justin Cotney, Koray Ozduman, Timuçin Avşar, Jie Li, Phillip B Murray, Octavian Henegariu,[...]. Science 2013
Victoria E Clark, E Zeynep Erson-Omay, Akdes Serin, Jun Yin, Justin Cotney, Koray Ozduman, Timuçin Avşar, Jie Li, Phillip B Murray, Octavian Henegariu,[...]. Science 2013
72
Genomic sequencing of meningiomas identifies oncogenic SMO and AKT1 mutations.
Priscilla K Brastianos, Peleg M Horowitz, Sandro Santagata, Robert T Jones, Aaron McKenna, Gad Getz, Keith L Ligon, Emanuele Palescandolo, Paul Van Hummelen, Matthew D Ducar,[...]. Nat Genet 2013
Priscilla K Brastianos, Peleg M Horowitz, Sandro Santagata, Robert T Jones, Aaron McKenna, Gad Getz, Keith L Ligon, Emanuele Palescandolo, Paul Van Hummelen, Matthew D Ducar,[...]. Nat Genet 2013
62
Secretory meningiomas are defined by combined KLF4 K409Q and TRAF7 mutations.
David E Reuss, Rosario M Piro, David T W Jones, Matthias Simon, Ralf Ketter, Marcel Kool, Albert Becker, Felix Sahm, Stefan Pusch, Jochen Meyer,[...]. Acta Neuropathol 2013
David E Reuss, Rosario M Piro, David T W Jones, Matthias Simon, Ralf Ketter, Marcel Kool, Albert Becker, Felix Sahm, Stefan Pusch, Jochen Meyer,[...]. Acta Neuropathol 2013
47
Oncogenic PI3K mutations are as common as AKT1 and SMO mutations in meningioma.
Malak Abedalthagafi, Wenya Linda Bi, Ayal A Aizer, Parker H Merrill, Ryan Brewster, Pankaj K Agarwalla, Marc L Listewnik, Dora Dias-Santagata, Aaron R Thorner, Paul Van Hummelen,[...]. Neuro Oncol 2016
Malak Abedalthagafi, Wenya Linda Bi, Ayal A Aizer, Parker H Merrill, Ryan Brewster, Pankaj K Agarwalla, Marc L Listewnik, Dora Dias-Santagata, Aaron R Thorner, Paul Van Hummelen,[...]. Neuro Oncol 2016
41
The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary.
David N Louis, Arie Perry, Guido Reifenberger, Andreas von Deimling, Dominique Figarella-Branger, Webster K Cavenee, Hiroko Ohgaki, Otmar D Wiestler, Paul Kleihues, David W Ellison. Acta Neuropathol 2016
David N Louis, Arie Perry, Guido Reifenberger, Andreas von Deimling, Dominique Figarella-Branger, Webster K Cavenee, Hiroko Ohgaki, Otmar D Wiestler, Paul Kleihues, David W Ellison. Acta Neuropathol 2016
38
Recurrent somatic mutations in POLR2A define a distinct subset of meningiomas.
Victoria E Clark, Akdes Serin Harmancı, Hanwen Bai, Mark W Youngblood, Tong Ihn Lee, Jacob F Baranoski, A Gulhan Ercan-Sencicek, Brian J Abraham, Abraham S Weintraub, Denes Hnisz,[...]. Nat Genet 2016
Victoria E Clark, Akdes Serin Harmancı, Hanwen Bai, Mark W Youngblood, Tong Ihn Lee, Jacob F Baranoski, A Gulhan Ercan-Sencicek, Brian J Abraham, Abraham S Weintraub, Denes Hnisz,[...]. Nat Genet 2016
35
DNA methylation-based classification and grading system for meningioma: a multicentre, retrospective analysis.
Felix Sahm, Daniel Schrimpf, Damian Stichel, David T W Jones, Thomas Hielscher, Sebastian Schefzyk, Konstantin Okonechnikov, Christian Koelsche, David E Reuss, David Capper,[...]. Lancet Oncol 2017
Felix Sahm, Daniel Schrimpf, Damian Stichel, David T W Jones, Thomas Hielscher, Sebastian Schefzyk, Konstantin Okonechnikov, Christian Koelsche, David E Reuss, David Capper,[...]. Lancet Oncol 2017
32
High incidence of activating TERT promoter mutations in meningiomas undergoing malignant progression.
Stéphane Goutagny, Jean C Nault, Maxime Mallet, Dominique Henin, Jessica Z Rossi, Michel Kalamarides. Brain Pathol 2014
Stéphane Goutagny, Jean C Nault, Maxime Mallet, Dominique Henin, Jessica Z Rossi, Michel Kalamarides. Brain Pathol 2014
28
Pathological classification and molecular genetics of meningiomas.
Christian Mawrin, Arie Perry. J Neurooncol 2010
Christian Mawrin, Arie Perry. J Neurooncol 2010
28
TERT Promoter Mutations and Risk of Recurrence in Meningioma.
Felix Sahm, Daniel Schrimpf, Adriana Olar, Christian Koelsche, David Reuss, Juliane Bissel, Annekathrin Kratz, David Capper, Sebastian Schefzyk, Thomas Hielscher,[...]. J Natl Cancer Inst 2015
Felix Sahm, Daniel Schrimpf, Adriana Olar, Christian Koelsche, David Reuss, Juliane Bissel, Annekathrin Kratz, David Capper, Sebastian Schefzyk, Thomas Hielscher,[...]. J Natl Cancer Inst 2015
28
NF2/merlin is a novel negative regulator of mTOR complex 1, and activation of mTORC1 is associated with meningioma and schwannoma growth.
Marianne F James, Sangyeul Han, Carolyn Polizzano, Scott R Plotkin, Brendan D Manning, Anat O Stemmer-Rachamimov, James F Gusella, Vijaya Ramesh. Mol Cell Biol 2009
Marianne F James, Sangyeul Han, Carolyn Polizzano, Scott R Plotkin, Brendan D Manning, Anat O Stemmer-Rachamimov, James F Gusella, Vijaya Ramesh. Mol Cell Biol 2009
25
Loss-of-function mutations in SMARCE1 cause an inherited disorder of multiple spinal meningiomas.
Miriam J Smith, James O'Sullivan, Sanjeev S Bhaskar, Kristen D Hadfield, Gemma Poke, John Caird, Saba Sharif, Diana Eccles, David Fitzpatrick, Daniel Rawluk,[...]. Nat Genet 2013
Miriam J Smith, James O'Sullivan, Sanjeev S Bhaskar, Kristen D Hadfield, Gemma Poke, John Caird, Saba Sharif, Diana Eccles, David Fitzpatrick, Daniel Rawluk,[...]. Nat Genet 2013
25
BAP1 mutations in high-grade meningioma: implications for patient care.
Ganesh M Shankar, Sandro Santagata. Neuro Oncol 2017
Ganesh M Shankar, Sandro Santagata. Neuro Oncol 2017
30
Analysis of the neurofibromatosis 2 gene reveals molecular variants of meningioma.
R Wellenreuther, J A Kraus, D Lenartz, A G Menon, J Schramm, D N Louis, V Ramesh, J F Gusella, O D Wiestler, A von Deimling. Am J Pathol 1995
R Wellenreuther, J A Kraus, D Lenartz, A G Menon, J Schramm, D N Louis, V Ramesh, J F Gusella, O D Wiestler, A von Deimling. Am J Pathol 1995
22
The recurrence of intracranial meningiomas after surgical treatment.
D SIMPSON. J Neurol Neurosurg Psychiatry 1957
D SIMPSON. J Neurol Neurosurg Psychiatry 1957
22
Meningiomas: knowledge base, treatment outcomes, and uncertainties. A RANO review.
Leland Rogers, Igor Barani, Marc Chamberlain, Thomas J Kaley, Michael McDermott, Jeffrey Raizer, David Schiff, Damien C Weber, Patrick Y Wen, Michael A Vogelbaum. J Neurosurg 2015
Leland Rogers, Igor Barani, Marc Chamberlain, Thomas J Kaley, Michael McDermott, Jeffrey Raizer, David Schiff, Damien C Weber, Patrick Y Wen, Michael A Vogelbaum. J Neurosurg 2015
22
"Malignancy" in meningiomas: a clinicopathologic study of 116 patients, with grading implications.
A Perry, B W Scheithauer, S L Stafford, C M Lohse, P C Wollan. Cancer 1999
A Perry, B W Scheithauer, S L Stafford, C M Lohse, P C Wollan. Cancer 1999
21
mTORC1 inhibitors suppress meningioma growth in mouse models.
Doreen Pachow, Nadine Andrae, Nadine Kliese, Frank Angenstein, Oliver Stork, Annette Wilisch-Neumann, Elmar Kirches, Christian Mawrin. Clin Cancer Res 2013
Doreen Pachow, Nadine Andrae, Nadine Kliese, Frank Angenstein, Oliver Stork, Annette Wilisch-Neumann, Elmar Kirches, Christian Mawrin. Clin Cancer Res 2013
29
Germline SMARCE1 mutations predispose to both spinal and cranial clear cell meningiomas.
Miriam J Smith, Andrew J Wallace, Chris Bennett, Martin Hasselblatt, Ewelina Elert-Dobkowska, Linton T Evans, William F Hickey, Jack van Hoff, David Bauer, Amy Lee,[...]. J Pathol 2014
Miriam J Smith, Andrew J Wallace, Chris Bennett, Martin Hasselblatt, Ewelina Elert-Dobkowska, Linton T Evans, William F Hickey, Jack van Hoff, David Bauer, Amy Lee,[...]. J Pathol 2014
25
Germline and somatic BAP1 mutations in high-grade rhabdoid meningiomas.
Ganesh M Shankar, Malak Abedalthagafi, Rachael A Vaubel, Parker H Merrill, Naema Nayyar, Corey M Gill, Ryan Brewster, Wenya Linda Bi, Pankaj K Agarwalla, Aaron R Thorner,[...]. Neuro Oncol 2017
Ganesh M Shankar, Malak Abedalthagafi, Rachael A Vaubel, Parker H Merrill, Naema Nayyar, Corey M Gill, Ryan Brewster, Wenya Linda Bi, Pankaj K Agarwalla, Aaron R Thorner,[...]. Neuro Oncol 2017
29
Integrated genomic analyses of de novo pathways underlying atypical meningiomas.
Akdes Serin Harmancı, Mark W Youngblood, Victoria E Clark, Süleyman Coşkun, Octavian Henegariu, Daniel Duran, E Zeynep Erson-Omay, Leon D Kaulen, Tong Ihn Lee, Brian J Abraham,[...]. Nat Commun 2017
Akdes Serin Harmancı, Mark W Youngblood, Victoria E Clark, Süleyman Coşkun, Octavian Henegariu, Daniel Duran, E Zeynep Erson-Omay, Leon D Kaulen, Tong Ihn Lee, Brian J Abraham,[...]. Nat Commun 2017
21
Genomic profiling reveals alternative genetic pathways of meningioma malignant progression dependent on the underlying NF2 status.
Stéphane Goutagny, Hong Wei Yang, Jessica Zucman-Rossi, Jennifer Chan, Jonathan M Dreyfuss, Peter J Park, Peter M Black, Marco Giovannini, Rona S Carroll, Michel Kalamarides. Clin Cancer Res 2010
Stéphane Goutagny, Hong Wei Yang, Jessica Zucman-Rossi, Jennifer Chan, Jonathan M Dreyfuss, Peter J Park, Peter M Black, Marco Giovannini, Rona S Carroll, Michel Kalamarides. Clin Cancer Res 2010
27
AKT1E17K mutations cluster with meningothelial and transitional meningiomas and can be detected by SFRP1 immunohistochemistry.
Felix Sahm, Juliane Bissel, Christian Koelsche, Leonille Schweizer, David Capper, David Reuss, Katja Böhmer, Ulrike Lass, Tanja Göck, Katrin Kalis,[...]. Acta Neuropathol 2013
Felix Sahm, Juliane Bissel, Christian Koelsche, Leonille Schweizer, David Capper, David Reuss, Katja Böhmer, Ulrike Lass, Tanja Göck, Katrin Kalis,[...]. Acta Neuropathol 2013
27
Genomic landscape of high-grade meningiomas.
Wenya Linda Bi, Noah F Greenwald, Malak Abedalthagafi, Jeremiah Wala, Will J Gibson, Pankaj K Agarwalla, Peleg Horowitz, Steven E Schumacher, Ekaterina Esaulova, Yu Mei,[...]. NPJ Genom Med 2017
Wenya Linda Bi, Noah F Greenwald, Malak Abedalthagafi, Jeremiah Wala, Will J Gibson, Pankaj K Agarwalla, Peleg Horowitz, Steven E Schumacher, Ekaterina Esaulova, Yu Mei,[...]. NPJ Genom Med 2017
22
NF2 status of meningiomas is associated with tumour localization and histology.
J Kros, K de Greve, A van Tilborg, W Hop, H Pieterman, C Avezaat, R Lekanne Dit Deprez, E Zwarthoff. J Pathol 2001
J Kros, K de Greve, A van Tilborg, W Hop, H Pieterman, C Avezaat, R Lekanne Dit Deprez, E Zwarthoff. J Pathol 2001
23
Phase II trial of sunitinib for recurrent and progressive atypical and anaplastic meningioma.
Thomas J Kaley, Patrick Wen, David Schiff, Keith Ligon, Sam Haidar, Sasan Karimi, Andrew B Lassman, Craig P Nolan, Lisa M DeAngelis, Igor Gavrilovic,[...]. Neuro Oncol 2015
Thomas J Kaley, Patrick Wen, David Schiff, Keith Ligon, Sam Haidar, Sasan Karimi, Andrew B Lassman, Craig P Nolan, Lisa M DeAngelis, Igor Gavrilovic,[...]. Neuro Oncol 2015
18
The molecular genetics and tumor pathogenesis of meningiomas and the future directions of meningioma treatments.
Winward Choy, Won Kim, Daniel Nagasawa, Stephanie Stramotas, Andrew Yew, Quinton Gopen, Andrew T Parsa, Isaac Yang. Neurosurg Focus 2011
Winward Choy, Won Kim, Daniel Nagasawa, Stephanie Stramotas, Andrew Yew, Quinton Gopen, Andrew T Parsa, Isaac Yang. Neurosurg Focus 2011
17
A novel moesin-, ezrin-, radixin-like gene is a candidate for the neurofibromatosis 2 tumor suppressor.
J A Trofatter, M M MacCollin, J L Rutter, J R Murrell, M P Duyao, D M Parry, R Eldridge, N Kley, A G Menon, K Pulaski. Cell 1993
J A Trofatter, M M MacCollin, J L Rutter, J R Murrell, M P Duyao, D M Parry, R Eldridge, N Kley, A G Menon, K Pulaski. Cell 1993
17
Alteration in a new gene encoding a putative membrane-organizing protein causes neuro-fibromatosis type 2.
G A Rouleau, P Merel, M Lutchman, M Sanson, J Zucman, C Marineau, K Hoang-Xuan, S Demczuk, C Desmaze, B Plougastel. Nature 1993
G A Rouleau, P Merel, M Lutchman, M Sanson, J Zucman, C Marineau, K Hoang-Xuan, S Demczuk, C Desmaze, B Plougastel. Nature 1993
17
Identification of a progenitor cell of origin capable of generating diverse meningioma histological subtypes.
M Kalamarides, A O Stemmer-Rachamimov, M Niwa-Kawakita, F Chareyre, E Taranchon, Z-Y Han, C Martinelli, E A Lusis, B Hegedus, D H Gutmann,[...]. Oncogene 2011
M Kalamarides, A O Stemmer-Rachamimov, M Niwa-Kawakita, F Chareyre, E Taranchon, Z-Y Han, C Martinelli, E A Lusis, B Hegedus, D H Gutmann,[...]. Oncogene 2011
18
Historical benchmarks for medical therapy trials in surgery- and radiation-refractory meningioma: a RANO review.
Thomas Kaley, Igor Barani, Marc Chamberlain, Michael McDermott, Katherine Panageas, Jeffrey Raizer, Leland Rogers, David Schiff, Michael Vogelbaum, Damien Weber,[...]. Neuro Oncol 2014
Thomas Kaley, Igor Barani, Marc Chamberlain, Michael McDermott, Katherine Panageas, Jeffrey Raizer, Leland Rogers, David Schiff, Michael Vogelbaum, Damien Weber,[...]. Neuro Oncol 2014
17
The 2007 WHO classification of tumours of the central nervous system.
David N Louis, Hiroko Ohgaki, Otmar D Wiestler, Webster K Cavenee, Peter C Burger, Anne Jouvet, Bernd W Scheithauer, Paul Kleihues. Acta Neuropathol 2007
David N Louis, Hiroko Ohgaki, Otmar D Wiestler, Webster K Cavenee, Peter C Burger, Anne Jouvet, Bernd W Scheithauer, Paul Kleihues. Acta Neuropathol 2007
16
A prognostic cytogenetic scoring system to guide the adjuvant management of patients with atypical meningioma.
Ayal A Aizer, Malak Abedalthagafi, Wenya Linda Bi, Margaret C Horvath, Nils D Arvold, Ossama Al-Mefty, Eudocia Q Lee, Lakshmi Nayak, Mikael L Rinne, Andrew D Norden,[...]. Neuro Oncol 2016
Ayal A Aizer, Malak Abedalthagafi, Wenya Linda Bi, Margaret C Horvath, Nils D Arvold, Ossama Al-Mefty, Eudocia Q Lee, Lakshmi Nayak, Mikael L Rinne, Andrew D Norden,[...]. Neuro Oncol 2016
33
Role of Merlin/NF2 inactivation in tumor biology.
A M Petrilli, C Fernández-Valle. Oncogene 2016
A M Petrilli, C Fernández-Valle. Oncogene 2016
16
Nf2 gene inactivation in arachnoidal cells is rate-limiting for meningioma development in the mouse.
Michel Kalamarides, Michiko Niwa-Kawakita, Hélène Leblois, Vincent Abramowski, Michel Perricaudet, Anne Janin, Gilles Thomas, David H Gutmann, Marco Giovannini. Genes Dev 2002
Michel Kalamarides, Michiko Niwa-Kawakita, Hélène Leblois, Vincent Abramowski, Michel Perricaudet, Anne Janin, Gilles Thomas, David H Gutmann, Marco Giovannini. Genes Dev 2002
15
Analysis of genomic alterations in benign, atypical, and anaplastic meningiomas: toward a genetic model of meningioma progression.
R G Weber, J Boström, M Wolter, M Baudis, V P Collins, G Reifenberger, P Lichter. Proc Natl Acad Sci U S A 1997
R G Weber, J Boström, M Wolter, M Baudis, V P Collins, G Reifenberger, P Lichter. Proc Natl Acad Sci U S A 1997
15
Epidemiology and etiology of meningioma.
Joseph Wiemels, Margaret Wrensch, Elizabeth B Claus. J Neurooncol 2010
Joseph Wiemels, Margaret Wrensch, Elizabeth B Claus. J Neurooncol 2010
15
Angiomatous meningiomas have a distinct genetic profile with multiple chromosomal polysomies including polysomy of chromosome 5.
Malak S Abedalthagafi, Parker H Merrill, Wenya Linda Bi, Robert T Jones, Marc L Listewnik, Shakti H Ramkissoon, Aaron R Thorner, Ian F Dunn, Rameen Beroukhim, Brian M Alexander,[...]. Oncotarget 2014
Malak S Abedalthagafi, Parker H Merrill, Wenya Linda Bi, Robert T Jones, Marc L Listewnik, Shakti H Ramkissoon, Aaron R Thorner, Ian F Dunn, Rameen Beroukhim, Brian M Alexander,[...]. Oncotarget 2014
38
EANO guidelines for the diagnosis and treatment of meningiomas.
Roland Goldbrunner, Giuseppe Minniti, Matthias Preusser, Michael D Jenkinson, Kita Sallabanda, Emmanuel Houdart, Andreas von Deimling, Pantelis Stavrinou, Florence Lefranc, Morten Lund-Johansen,[...]. Lancet Oncol 2016
Roland Goldbrunner, Giuseppe Minniti, Matthias Preusser, Michael D Jenkinson, Kita Sallabanda, Emmanuel Houdart, Andreas von Deimling, Pantelis Stavrinou, Florence Lefranc, Morten Lund-Johansen,[...]. Lancet Oncol 2016
15
SMO mutation status defines a distinct and frequent molecular subgroup in olfactory groove meningiomas.
Julien Boetto, Franck Bielle, Marc Sanson, Matthieu Peyre, Michel Kalamarides. Neuro Oncol 2017
Julien Boetto, Franck Bielle, Marc Sanson, Matthieu Peyre, Michel Kalamarides. Neuro Oncol 2017
29
Advances in meningioma genetics: novel therapeutic opportunities.
Matthias Preusser, Priscilla K Brastianos, Christian Mawrin. Nat Rev Neurol 2018
Matthias Preusser, Priscilla K Brastianos, Christian Mawrin. Nat Rev Neurol 2018
19
Different activation of mitogen-activated protein kinase and Akt signaling is associated with aggressive phenotype of human meningiomas.
Christian Mawrin, Tina Sasse, Elmar Kirches, Siegfried Kropf, Thomas Schneider, Christoph Grimm, Claudia Pambor, Christian K Vorwerk, Raimund Firsching, Uwe Lendeckel,[...]. Clin Cancer Res 2005
Christian Mawrin, Tina Sasse, Elmar Kirches, Siegfried Kropf, Thomas Schneider, Christoph Grimm, Claudia Pambor, Christian K Vorwerk, Raimund Firsching, Uwe Lendeckel,[...]. Clin Cancer Res 2005
15
Genomic landscape of intracranial meningiomas.
Wenya Linda Bi, Malak Abedalthagafi, Peleg Horowitz, Pankaj K Agarwalla, Yu Mei, Ayal A Aizer, Ryan Brewster, Gavin P Dunn, Ossama Al-Mefty, Brian M Alexander,[...]. J Neurosurg 2016
Wenya Linda Bi, Malak Abedalthagafi, Peleg Horowitz, Pankaj K Agarwalla, Yu Mei, Ayal A Aizer, Ryan Brewster, Gavin P Dunn, Ossama Al-Mefty, Brian M Alexander,[...]. J Neurosurg 2016
23
Alterations of the tumor suppressor genes CDKN2A (p16(INK4a)), p14(ARF), CDKN2B (p15(INK4b)), and CDKN2C (p18(INK4c)) in atypical and anaplastic meningiomas.
J Boström, B Meyer-Puttlitz, M Wolter, B Blaschke, R G Weber, P Lichter, K Ichimura, V P Collins, G Reifenberger. Am J Pathol 2001
J Boström, B Meyer-Puttlitz, M Wolter, B Blaschke, R G Weber, P Lichter, K Ichimura, V P Collins, G Reifenberger. Am J Pathol 2001
13
Increased expression of the immune modulatory molecule PD-L1 (CD274) in anaplastic meningioma.
Ziming Du, Malak Abedalthagafi, Ayal A Aizer, Allison R McHenry, Heather H Sun, Mark-Anthony Bray, Omar Viramontes, Revaz Machaidze, Priscilla K Brastianos, David A Reardon,[...]. Oncotarget 2015
Ziming Du, Malak Abedalthagafi, Ayal A Aizer, Allison R McHenry, Heather H Sun, Mark-Anthony Bray, Omar Viramontes, Revaz Machaidze, Priscilla K Brastianos, David A Reardon,[...]. Oncotarget 2015
14
A phase II trial of bevacizumab and everolimus as treatment for patients with refractory, progressive intracranial meningioma.
Kent C Shih, Sajeel Chowdhary, Paul Rosenblatt, Alva B Weir, Gregg C Shepard, Jeffrey T Williams, Mythili Shastry, Howard A Burris, John D Hainsworth. J Neurooncol 2016
Kent C Shih, Sajeel Chowdhary, Paul Rosenblatt, Alva B Weir, Gregg C Shepard, Jeffrey T Williams, Mythili Shastry, Howard A Burris, John D Hainsworth. J Neurooncol 2016
26
DNA methylation profiling to predict recurrence risk in meningioma: development and validation of a nomogram to optimize clinical management.
Farshad Nassiri, Yasin Mamatjan, Suganth Suppiah, Jetan H Badhiwala, Sheila Mansouri, Shirin Karimi, Olli Saarela, Laila Poisson, Irina Gepfner-Tuma, Jens Schittenhelm,[...]. Neuro Oncol 2019
Farshad Nassiri, Yasin Mamatjan, Suganth Suppiah, Jetan H Badhiwala, Sheila Mansouri, Shirin Karimi, Olli Saarela, Laila Poisson, Irina Gepfner-Tuma, Jens Schittenhelm,[...]. Neuro Oncol 2019
15
Histological classification and molecular genetics of meningiomas.
Markus J Riemenschneider, Arie Perry, Guido Reifenberger. Lancet Neurol 2006
Markus J Riemenschneider, Arie Perry, Guido Reifenberger. Lancet Neurol 2006
12
A role for chromosome 9p21 deletions in the malignant progression of meningiomas and the prognosis of anaplastic meningiomas.
Arie Perry, Ruma Banerjee, Christine M Lohse, Bette K Kleinschmidt-DeMasters, Bernd W Scheithauer. Brain Pathol 2002
Arie Perry, Ruma Banerjee, Christine M Lohse, Bette K Kleinschmidt-DeMasters, Bernd W Scheithauer. Brain Pathol 2002
12
AKT1(E17K) in human solid tumours.
F E Bleeker, L Felicioni, F Buttitta, S Lamba, L Cardone, M Rodolfo, A Scarpa, S Leenstra, M Frattini, M Barbareschi,[...]. Oncogene 2008
F E Bleeker, L Felicioni, F Buttitta, S Lamba, L Cardone, M Rodolfo, A Scarpa, S Leenstra, M Frattini, M Barbareschi,[...]. Oncogene 2008
12
Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.